Share Price
Ticker: KDEV List: NASDAQ OMX
Volume:
Press Releases
-
2017-09-13
Karolinska Development's portfolio company Umecrine Cognition presents positive phase 1b data for its drug candidate against hepatic encephalopathy
-
2017-09-13
Karolinska Development's portfolio company BioArctic intends to list on Nasdaq Stockholm
-
2017-08-31
Change of Number of Shares and Votes in Karolinska Development
News
-
2017-09-14
Karolinska Developments's portfolio company Modus Therapeutics recruits new Chief Medical Officer
-
2017-09-05
Karolinska Development company Umecrine Cognition appoints Dr. Thomas P. Blackburn to its board of directors
-
2017-08-02
Karolinska Development company Aprea Therapeutics announces First Patient Enrolled in Phase Ib/II Clinical Study
